Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer. | Front Immunol | 2023 | 37691919 | PubTator, text mining | PubMed |
| Prevalence of anti-beta-1 antibody 6 months after hospitalization for acute heart failure predicts adverse outcome. | ESC Heart Fail | 2023 | 37688355 | PubTator, text mining | PubMed |
| Differentiation and Characterization of Cystic Fibrosis Transmembrane Conductance Regulator Knockout Human Pluripotent Stem Cells into Salivary Gland Epithelial Progenitors. | Int J Stem Cells | 2023 | 37670513 | PubTator, text mining | PubMed |
| A 20:1 synergetic mixture of cafedrine/theodrenaline accelerates particle transport velocity in murine tracheal epithelium via IP3 receptor-associated calcium release. | Front Pharmacol | 2023 | 37654612 | PubTator, text mining | PubMed |
| Is there a role for bradykinin in cerebral malaria pathogenesis? | Front Cell Infect Microbiol | 2023 | 37637466 | PubTator, text mining | PubMed |
| Bradykinin B1 Receptor Affects Tumor-Associated Macrophage Activity and Glioblastoma Progression. | Antioxidants (Basel) | 2023 | 37627528 | PubTator, text mining | PubMed |
| Emerging Role of Kinin B1 Receptor in Persistent Neuroinflammation and Neuropsychiatric Symptoms in Mice Following Recovery from SARS-CoV-2 Infection. | Cells | 2023 | 37626917 | PubTator, text mining | PubMed |
| Enhancing understanding of SARS-CoV-2 infection among individuals with Down syndrome: An integrative review. | Sao Paulo Med J | 2023 | 37610949 | PubTator, text mining | PubMed |
| Cardiac mechanics and reverse remodelling under mechanical support from left ventricular assist devices. | Front Cardiovasc Med | 2023 | 37600037 | PubTator, text mining | PubMed |
| Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives. | Front Bioeng Biotechnol | 2023 | 37576994 | PubTator, text mining | PubMed |
| Angiotensin Regulation of Vascular Homeostasis: Exploring the Role of ROS and RAS Blockers. | Int J Mol Sci | 2023 | 37569484 | PubTator, text mining | PubMed |
| Characterizing Sjögren-Associated Fatigue: A Distinct Phenotype from ME/CFS. | J Clin Med | 2023 | 37568396 | PubTator, text mining | PubMed |
| The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers. | Pulm Pharmacol Ther | 2023 | 37562641 | PubTator, text mining | PubMed |
| Genetic Programs Between Steroid-Sensitive and Steroid-Insensitive Interstitial Lung Disease. | Inflammation | 2023 | 37561311 | PubTator, text mining | PubMed |
| Driving force of deteriorated cellular environment in heart failure: Metabolic remodeling. | Clinics (Sao Paulo) | 2023 | 37557005 | PubTator, text mining | PubMed |
| The Renin-Angiotensin System in COVID-19: Can Long COVID Be Predicted? | Life (Basel) | 2023 | 37511837 | PubTator, text mining | PubMed |
| Role of the Renin-Angiotensin System in Long COVID's Cardiovascular Injuries. | Biomedicines | 2023 | 37509643 | PubTator, text mining | PubMed |
| The Effects of Serping1 siRNA in α-Synuclein Regulation in MPTP-Induced Parkinson's Disease. | Biomedicines | 2023 | 37509591 | PubTator, text mining | PubMed |
| QHRD106 ameliorates ischemic stroke injury as a long-acting tissue kallikrein preparation. | iScience | 2023 | 37496671 | PubTator, text mining | PubMed |
| Role of aspirin, beta-blocker, statins, and heparin therapy in septic patients under mechanical ventilation: a narrative review. | Front Med (Lausanne) | 2023 | 37492248 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=7